Jubilant Pharmova Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ESOMEPRAZOLE SODIUM, with a corresponding US DMF Number 23628.
Remarkably, this DMF maintains an Active status since its submission on May 26, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 28, 2016, and payment made on June 16, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II